Aptorum Group Market Risk Adjusted Performance

APM Stock  USD 0.95  0.05  5.00%   
Aptorum Group market-risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for Aptorum Group Ltd or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
Aptorum Group Ltd has current Market Risk Adjusted Performance of (0.66).

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
(0.66)
ER[a] = Expected return on investing in Aptorum Group
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Aptorum Group Market Risk Adjusted Performance Peers Comparison

0-0.65680.17460.2415-0.2322100%

Aptorum Market Risk Adjusted Performance Relative To Other Indicators

Aptorum Group Ltd is rated below average in market risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers .
JavaScript chart by amCharts 3.21.15IPHAREVBDRMAAIMUNCYSRZNAPM 020406080100120140 -0.500.51.01.52.0
Compare Aptorum Group to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Trending Assets

ADXN
Addex Therapeutics
8.50  0.05  0.59 
CYAD
Celyad SA
0.00  0.00  0.00 
AMTI
Applied Molecular
0.00  0.00  0.00 
SRZN
Surrozen
11.47  -0.37  -3.12 
CYTO
Altamira Therapeutics
0.00  0.00  0.00 
BCDA
Biocardia
2.01  -0.03  -1.47 
DYAI
Dyadic International
1.47  0.03  2.08 
NRBO
Neurobo Pharmaceuticals
1.89  -0.11  -5.5 
ARMP
Armata Pharmaceuticals
1.99  -0.09  -4.33 
DRMA
Dermata Therapeutics
1.14  -0.02  -1.72 
ERYP
Erytech Pharma SA
0.00  0.00  0.00 
AIM
AIM ImmunoTech
0.14  0.01  7.69 
CFRX
ContraFect Corp
0.00  0.00  0.00 
IPHA
Innate Pharma
2.12  -0.04  -1.85 
REVB
Revelation Biosciences
3.49  -0.05  -1.41 
FRTX
Fresh Tracks Therapeutics
0.00  0.00  0.00 
ADTX
Aditxt Inc
0.06  -0.007  -10.14 
EFTR
Effector Therapeutics
0.00  0.00  0.00 
UNCY
Unicycive Therapeutics
0.55  -0.01  -1.79